Bivatuzumab mertansine is a combination of bivatuzumab, a humanized monoclonal antibody, and mertansine, a cytotoxic agent. It is designed for the treatment of squamous cell carcinoma.

PropertyValue
dbpedia-owl:abstract
  • Bivatuzumab mertansine is a combination of bivatuzumab, a humanized monoclonal antibody, and mertansine, a cytotoxic agent. It is designed for the treatment of squamous cell carcinoma.
dbpedia-owl:atcPrefix
  • none
dbpedia-owl:thumbnail
dbpprop:atcPrefix
  • none
dbpprop:mabType
  • mab
dbpprop:source
  • zu/o
dbpprop:target
  • CD44 v6
dbpprop:type
  • mab
dbpprop:verifiedrevid
  • 400278734 (xsd:integer)
dbpprop:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Bivatuzumab mertansine is a combination of bivatuzumab, a humanized monoclonal antibody, and mertansine, a cytotoxic agent. It is designed for the treatment of squamous cell carcinoma.
rdfs:label
  • Bivatuzumab mertansine
owl:sameAs
foaf:depiction
foaf:page
is dbpedia-owl:wikiPageRedirects of
is owl:sameAs of
is foaf:primaryTopic of